my csl thoughts are that if they make a drug a year from now on, which seems possible, and each one has say 2B US$ in potential revenue, and we have a PE of 10(which is low, but allows for costs and exch rate in the first number), then each year our mcap should increase by approx 20B. And we are nowhere near a MCAP of 1B. So, i do feel there is potential everlasting mcap expansion is probable, , and dilution seems less likely each day.
PYC Price at posting:
10.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)